To investigate the clinicopathologic significance of CD73 expression in PTC, the 511 patients were divided into high (n = 370) and low (n = 141) expression groups according to a cut-off value of 10% of CD73 immunostained tumor cells (Table 1). Here, NT5E is linked to neoplasm.